Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting
nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find
and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate
disodium and gadobutrol, may help doctors to see MRI images more clearly.